|
Volumn 7, Issue 8, 2012, Pages 1365-1368
|
Cardiovascular Properties of a Nitric Oxide Releasing Rofecoxib Analogue: Beneficial Anti-hypertensive Activity and Enhanced Recovery in an Ischemic Reperfusion Injury Model
|
Author keywords
Anti hypertensive; Biological activity; Drug design; Ischemia reperfusion injury; Nitric oxide donor
|
Indexed keywords
CYCLOOXYGENASE 2 INHIBITOR;
N HYDROXY 4 [4 (4 CHLOROPHENYL) 5 OXO 2,5 DIHYDROFURAN 3 YL]BENZENESULFONAMIDE;
NITRIC OXIDE;
NITRIC OXIDE DONOR;
PHOSPHATE BUFFERED SALINE;
ROFECOXIB;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIHYPERTENSIVE ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
BINDING SITE;
CONTROLLED STUDY;
DIASTOLIC BLOOD PRESSURE;
FEMALE;
HEART MUSCLE ISCHEMIA;
HEART RATE;
IC 50;
IN VIVO STUDY;
INCUBATION TIME;
MALE;
MEAN ARTERIAL PRESSURE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
REPERFUSION INJURY;
SYSTOLIC BLOOD PRESSURE;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CYCLOOXYGENASE 2;
DISEASE MODELS, ANIMAL;
DRUG DESIGN;
FEMALE;
HEART RATE;
LACTONES;
MICE;
MICE, INBRED C57BL;
NITRIC OXIDE;
NITRIC OXIDE DONORS;
REPERFUSION INJURY;
SULFONES;
|
EID: 84864397701
PISSN: 18607179
EISSN: 18607187
Source Type: Journal
DOI: 10.1002/cmdc.201200234 Document Type: Article |
Times cited : (20)
|
References (16)
|